![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Structure Gallery
2281 structures found

CBLB
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Counted |
||

SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

PRMT3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

DCAF1
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||

53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

pfPKG
Target Class: Kinase-Other Disease Areas: Parasitic disease Site: Toronto Status: MedChem |
||

EIF2A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||

COPB2
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: MedChem |
||

COPB2
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||

TRIP12
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||

DCAF1
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling Site: Toronto Status: MedChem |
||

CARM1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

PRMT9
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

SEC31A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||

DCAF1
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||

GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: MedChem |
||

GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: MedChem |
||

UTP15
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||

PRMT9
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

PAFAH1B1
Target Class: WDR Disease Areas: Neurobiology Site: Toronto Status: Counted |
||

TMPRSS2
Target Class: Proteases Disease Areas: COVID Site: Toronto Status: Counted |
||

RBBP7
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

PPP1R10
Target Class: Miscellaneous Disease Areas: Cancer Site: Status: Counted |
||

WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

BRD1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

EED
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

WDR55
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||

KIF21A
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||

FEM1C
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Counted |
||

FEM1C
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Counted |
||

SCAF4
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Counted |
||

WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

GID4
Target Class: Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||

CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||

CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||

CVNSP3B
Target Class: Disease Areas: SARS-COV-2 Site: Frankfurt Status: |
||

FBXW11/SKP1 - Beta Catenin
Target Class: Ubiquitylation - E3 Ligases, WDR Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||

WDR41
Target Class: WDR Disease Areas: Cancer Site: Toronto Status: Counted |
||

PHF1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

PHF1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

PHF19
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

NLE1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||

WDR91
Target Class: WDR Disease Areas: Signalling Site: Toronto Status: Counted |
||

PPP1R10
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||

TEAD2
Target Class: Miscellaneous Disease Areas: Signalling and cancer Site: Toronto Status: Follow-up official |
||

UHRF1
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

TDRD3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

CDYL2
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

CDY1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

MPP8
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

CDYL2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

53BP1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

HAT1
Target Class: Chromatin Regulation, Transferases Disease Areas: Epigenetics Site: Toronto Status: Follow-up official |
||

DHTKD1
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Counted |
||

WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

ACVR1
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

MAPK14A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: Follow-up not counted |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

RAB39B
Target Class: Vesicle Transport Disease Areas: Cancer Site: Oxford Status: Counted |
||

RAB38
Target Class: Vesicle Transport Disease Areas: Cancer Site: Oxford Status: Counted |
||

HUWE1
Target Class: Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||

N6AMT1-TRMT112
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Counted |
||

PRMT9
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

COPA
Target Class: WDR Disease Areas: Neurobiology Site: Toronto Status: Counted |
||

HRMT1L6
Human protein arginine methyltransferase 6, full-length, in complex with covalent inhibitor YS17-117 Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

SUV39H2
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

WDR12
Target Class: Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Counted |
||

MSH6
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

MET12SCA
Target Class: Disease Areas: Site: Oxford Status: Official |
||

BDF2
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||

CLK3A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: Not counted |
||

CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Site: Frankfurt Status: MedChem |
||

PRMT7
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

MECP2
Target Class: Chromatin Regulation Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

MECP2
Target Class: Chromatin Regulation Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

HMCES
Human 5-hydroxymethylcytosine binding ES cell specific, SRAP domain, in complex with 3' overhang DNA Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Counted |
||

HMCES
Human 5-hydroxymethylcytosine binding ES cell specific, SRAP domain, cross-linked to DNA abasic site Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Counted |
||

HMCES
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Toronto Status: Not counted |
||

DYRK1AA
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Not counted |
||

ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

PRDM9
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: MedChem |
||

SLC14A1A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Official |
||

MBTD1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||

KCTD16A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||

ULK1A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||

ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Official |
||

ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||

ULK2A
Target Class: Protein Kinase Disease Areas: Autophagy and cancer Site: Frankfurt Status: Follow-up official |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||

CLK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||

PP-BRD18
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

SPIN1A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||

SPIN1A
Target Class: SPINDLIN Disease Areas: Site: Oxford Status: Follow-up not counted |
||

SPIN1A
Target Class: SPINDLIN Disease Areas: Site: Oxford Status: Follow-up not counted |
||

WDR12
Target Class: WDR Disease Areas: Signalling and cancer Site: Toronto Status: Counted |
||

STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||

STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||

SLKA
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: Follow-up official |
||

MLLT1A
Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94 (a SGC iMLLT derivative) Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||

MLL3
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

SETD3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

HUWE1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Counted |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: MedChem |
||

MLLT1A
Target Class: YEATS Disease Areas: Cancer and epigenetics Site: Frankfurt Status: Follow-up not counted |
||

DDR1A
Target Class: Kinase-TK Disease Areas: Site: Oxford Status: Follow-up not counted |
||

PP-BRD12
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Counted |
||

SETD3
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

RFXANK
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||

RIOK2A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Official |
||

DYRK2
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: MedChem |
||

DYRK2
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: MedChem |
||

FYN
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Not counted |
||

HCN4A
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Official |
||

USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||

KLHL20A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Follow-up official |
||

USP05
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling and cancer Site: Toronto Status: MedChem |
||

DDR1A
Target Class: Kinase-TK Disease Areas: Site: Oxford Status: |
||

CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

LOC149281
Target Class: Methyltransferases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||

STK10A
Target Class: Protein Kinase/STE Disease Areas: Site: Oxford Status: Follow-up not counted |
||

NUDT5A
Target Class: NUDIX Disease Areas: Site: Oxford Status: Follow-up official |
||

AURKC
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Counted |
||

AURKC
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

STK6
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: MedChem |
||

GALTA
Target Class: Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

HAO1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: |
||

GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||

HAO1A
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: |
||

GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||

GMDSA
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up not counted |
||

HAO1A
Target Class: Disease Areas: Site: Oxford Status: |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: |
||

ACVR1A
Target Class: Protein Kinase/TKL Disease Areas: Site: Oxford Status: |
||

MAPK3A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||

MBD1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

RFWD3
Target Class: WDR Disease Areas: Signalling and cancer Site: Toronto Status: Official |
||

MAPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Signalling and cancer Site: Frankfurt Status: Follow-up not counted |
||

PP-BRD13
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Status: Counted |
||

CARM1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

MBD3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

SP100A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

KCTD8A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Site: Oxford Status: Official |
||

SP100A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

XX01SUCLG1A
Target Class: Disease Areas: Site: Oxford Status: Official |
||

BRD2
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||

BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||

BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||

BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||

BRD4A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up not counted |
||

MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

DPAGT1A
Target Class: Membrane proteins Disease Areas: Neurobiology Site: Oxford Status: Follow-up official |
||

RIPK2
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: MedChem |
||

MLLT10
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

MLLT10 - DOT1L
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||

GID4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and metabolism Site: Toronto Status: Counted |
||

GID4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and metabolism Site: Toronto Status: Counted |
||

MBD3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

MBD2
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

ULK3
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Counted |
||

ULK3
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

MTHFRA
Target Class: Disease Areas: Site: Oxford Status: Official |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

EHMT1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

L3MBTL1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

WNK2A
Target Class: Protein Kinase/Other Disease Areas: Site: Oxford Status: |
||

RBBP4
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Status: Follow-up official |
||

RBBP4
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

B2MA
Target Class: Disease Areas: Site: Oxford Status: |
||

SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

SETDB1
Target Class: Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

SETDB1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up not counted |
||

RIPK2A
Target Class: Kinase-Other Disease Areas: Site: Oxford Status: |
||

STK10
Target Class: Protein Kinase/STE Disease Areas: Cancer Site: Oxford Status: MedChem |
||

FBXL19
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling and epigenetics Site: Toronto Status: Counted |
||

WNK2A
Target Class: Protein Kinase/Other Disease Areas: Site: Oxford Status: |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

TDRD2
Target Class: Methyl-lysine readers Disease Areas: Signalling and cancer Site: Toronto Status: Follow-up official |
||

JARID1BA
Target Class: Demethylase/Methyl-Lysine Reader, PHD domain Disease Areas: Cancer Site: Oxford Status: |
||

DENND1AA
Target Class: Disease Areas: Neurobiology Site: Oxford Status: Official |
||

SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Status: Follow-up not counted |
||

SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

TET1
Target Class: Miscellaneous Disease Areas: Cancer and epigenetics Site: Toronto Status: Counted |
||

KANK1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||

KANK1
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Counted |
||

KANK2
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||

EED
Target Class: WDR Disease Areas: Cancer and epigenetics Site: Status: Follow-up official |
||

CXXC5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

MBD1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||

SUV420H1
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: Follow-up official |
||

METTL13
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Counted |
||

MYST1
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

SMYD2
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: MedChem |
||

ABCB8A
Target Class: IMP/ABC Transporter Disease Areas: Metabolism Site: Oxford Status: Official |
||

HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||

HRMT1L6
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Status: Follow-up official |
||

SETD8
Target Class: Methyltransferases Disease Areas: Cancer and epigenetics Site: Toronto Status: MedChem |
||

DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

DCLRE1AA
Target Class: RNA/DNA Processing/DNA-Repair Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

DPAGT1A
Target Class: IMP/Enzyme Disease Areas: Neurobiology Site: Oxford Status: Follow-up official |
||

LIMK1A
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

LIMK2A
Target Class: Protein Kinase/TKL Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

XX02KALRNA
Target Class: Disease Areas: Signalling Site: Oxford Status: Official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

WNK3B
Target Class: Protein Kinase/Other Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

PARP14A
Target Class: Disease Areas: Metabolism Site: Oxford Status: Official |
||

AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

PP-BRD4
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

BRD4
Target Class: Bromodomain Disease Areas: Cancer and epigenetics Site: Oxford Status: MedChem |
||

KLHL3A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

DPYSL4A
Target Class: Disease Areas: Neurobiology Site: Oxford Status: Official |
||

XX09KEAP1A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Official |
||

CXXC4
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||

WHSC1
Target Class: Methyl-lysine readers Disease Areas: Cancer Site: Toronto Status: Official |
||

UBC
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||

RPUSD1
Target Class: Oxidoreductases Disease Areas: Signalling Site: Toronto Status: Official |
||

USP09X
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||

BAT8
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

EHMT1
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

RG9MTD1A
Target Class: Metabolic enzymes/Other Disease Areas: Metabolism Site: Oxford Status: Official |
||

SRPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||

BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

SRPK2A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

SRPK1A
Target Class: Protein Kinase/CMGC Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

YWHAZ
Target Class: Signalling proteins Disease Areas: Metabolism Site: Toronto Status: Follow-up official |
||

PGAM5A
Target Class: Phosphatases Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

RPUSD4
Target Class: Transferases Disease Areas: Chromatin and epigenetics, Signalling Site: Toronto Status: Pending-Official Structure |
||

LOC149281
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics, Signalling Site: Toronto Status: Pending-Official Structure |
||

TRIM33B
Target Class: Bromodomain, Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Official |
||

PIP3EA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

PRKCBP1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

BRD7A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

XX02MOCS2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

DCP2B
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

DPYSL2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||

CARM1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||

DPYSL2A
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Oxford Status: Pending-Official Structure |
||

TAF1A
Target Class: Bromodomain Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||

CREBBP
Target Class: Bromodomain Disease Areas: Cancer, Metabolism, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

EED
Target Class: WDR Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||

BAT8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics, Neurobiology Site: Toronto Status: Follow-up not counted |
||

EHMT1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

TDRD1A
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Pending-Official Structure |
||

SND1A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PF08_0034
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

SETD8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||

METTL3-METTL14
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

FAM83BA
Target Class: Cell Division Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

GEMIN5
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

GEMIN5
Target Class: WDR Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

PREB
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending - Official structure |
||

GEMIN5
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

DYRK2A
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

JAK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

JAK3A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

NUDT4A
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

SPIN2BA
Target Class: Chromatin Regulation Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||

SETD8
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: MedChem |
||

NUDT7A
Target Class: NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

CBX1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

CBX3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

NUDT17A
Target Class: Nucleotide metabolism, NUDIX Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

DPAGT1A
Target Class: IMP/Enzyme Disease Areas: Metabolism Site: Oxford Status: Official |
||

PP-BRD19
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending - Official structure |
||

tesst
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||

PUS7
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||

RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

RECQL5A
Target Class: DExD-DExH RNA helicases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||

HDAC6
Target Class: Ubiquitin Related Biology Disease Areas: Site: Toronto Status: MedChem |
||

SETDB1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||

HDAC6
Target Class: Transferases, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: MedChem |
||

MAPK14A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

AASSA
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

XX02LIMK1A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

CREBBPA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||

AAK1A
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up official |
||

PKD2A
Target Class: Membrane proteins Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

PP-BRD3
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

DOT1L
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

WNK1A
Target Class: Protein Kinase/Other Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

SART3
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||

SART3
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PP-PKAR
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

CLK1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

TDRD2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

THYN1
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

ZAKA
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Pending-Official Structure |
||

JMJD1CA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

GALTA
Target Class: Transferases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1CA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

DPF3
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

HRMT1L6
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

SIAH2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRD1A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRPF1B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

DDR1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

DDR1A
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PCAFA
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PP-BRD19
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

EMG1
Target Class: Transferases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||

JMJD2DA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2DA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Oxidoreductases Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

CBX8
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

CBX7
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

CBX2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

CBX4
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

PHIPA
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

WDR5
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

HRMT1L6
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

PANK2
Target Class: Non-protein Kinase Disease Areas: Metabolism, Signalling Site: Toronto Status: Pending-Official Structure |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up official |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||

AD-003
Target Class: Methyltransferases Disease Areas: Cancer Site: Toronto Status: Follow-up not counted |
||

PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

PAHA
Target Class: Amino oxidases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

PP-CDPK4
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||

ASPHA
Target Class: Amino oxidases Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

SMARCA2B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

SMARCA4A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

SMARCA2B
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

XX05CRK7A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

PP-BRD18
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics, Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

JMJD2AA
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BAZ2BA
Target Class: Bromodomain Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

POLQA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

POLQA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

GBE1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

GBE1A
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

KCTD17A
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Metabolism Site: Oxford Status: Official |
||

PTPN11
Target Class: Phosphatases Disease Areas: Signalling Site: Toronto Status: Follow-up official |
||

PP-PKG
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||

PP-BRD20
Target Class: Bromodomain Disease Areas: Site: Toronto Status: Pending-Official Structure |
||

ORC2
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||

NEDD4
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||

ITCH
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Cancer Site: Toronto Status: Official |
||

BRPF1
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

SLC2A3A
Target Class: Membrane proteins Disease Areas: Drug metabolism and toxicology Site: Oxford Status: Pending-Official Structure |
||

GRM7
Target Class: Miscellaneous Disease Areas: Signalling, Neurobiology Site: Toronto Status: Pending-Official Structure |
||

LdBPK_363130
Target Class: Bromodomain Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

SGF29
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

MMADHCMMA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending - Official structure |
||

JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

EP300A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRD2A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

TIF1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

SPIN3A
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending - Official structure |
||

UTYC
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Follow-up official |
||

JARID1BA
Target Class: Methyl-lysine readers Disease Areas: Site: Oxford Status: Pending - Official structure |
||

KCTD16A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||

CDK2A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

BRD1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

BRD1A
Target Class: Bromodomain Disease Areas: Site: Oxford Status: Follow-up official |
||

BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

TET3
Target Class: Miscellaneous Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

KCTD13A
Target Class: Ubiquitin Related Biology Disease Areas: Site: Oxford Status: Official |
||

RC3H2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||

RC3H2
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Official |
||

WHSC1L1
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||

BRD1
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||

PLRG1
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||

RC3H1
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Follow-up not counted |
||

PF13_0238
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||

ZCWPW2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

ZCWPW2
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||

DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PG1424PGA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Pending-Official Structure |
||

PG1424PGA
Target Class: Miscellaneous Disease Areas: Metabolism Site: Oxford Status: Follow-up official |
||

STK10A
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||

XX03GAKA
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

DYRK1AA
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up official |
||

PARP9B
Target Class: Poly ADP-ribose polymerase Disease Areas: Chromatin and epigenetics Site: Oxford Status: Pending-Official Structure |
||

DCLRE1AA
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Follow-up official |
||

PB1A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||

BRD9A
Target Class: Bromodomain Disease Areas: Chromatin and epigenetics Site: Oxford Status: Follow-up official |
||

BRD4A
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||